Phenominer Database Results (25 results)

 
 
Table "column sort" updates the order of the bars in the chart.
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Type Post Insult Time Value Post Insult Time Unit Method Notes Record ID Study ID
WKY renal filtration fraction puromycin aminonucleoside (50 mg/kg) Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. glomerular filtration trait male 0 days 9 0.29 null 0.02 0.06 p-aminohippurate analysis by liquid phase colorimetry 0.0 PA IV 50mg/kg 0 100606 2479
WKY renal filtration fraction controlled enalapril content drinking water (50 mg/l) (for 22 days) then puromycin aminonucleoside (50 mg/kg) Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. glomerular filtration trait male 0 days 5 0.09 null 0.01 0.02 p-aminohippurate analysis by liquid phase colorimetry 0.0 PA IV 50mg/kg 15 days 100474 2479
MWF/ZtmRrrc renal filtration fraction enalapril (50 mg/l) (for 182 days) Remuzzi A, et al., J Clin Invest. 1990 Feb;85(2):541-9. glomerular filtration trait male 246 days 6 0.3 null 0.02 0.04 p-aminohippurate analysis by liquid phase colorimetry 0.0 0 100946 2541
WKY renal filtration fraction 0.9% sodium chloride solution (3 ml) Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. glomerular filtration trait male 0 days 9 0.26 null 0.01 0.03 p-aminohippurate analysis by liquid phase colorimetry 0.0 0 100472 2479
MWF/Ztm renal filtration fraction arterial catheter implantation and controlled hemorrhage Remuzzi A, etal., Kidney Int. 1988 Oct;34(4):481-6. doi: 10.1038/ki.1988.206. glomerular filtration trait male 112 days-147 days 8 0.35 null 0.02 0.05 p-aminohippurate analysis by liquid phase colorimetry 0.0 0 109246 3138
MWF/ZtmRrrc renal filtration fraction enalapril (50 mg/l) (for 60 days) Remuzzi A, et al., J Clin Invest. 1990 Feb;85(2):541-9. glomerular filtration trait male 126 days 8 0.21 null 0.02 0.06 p-aminohippurate analysis by liquid phase colorimetry 0.0 0 100944 2541
WKY renal filtration fraction puromycin aminonucleoside (50 mg/kg) Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. glomerular filtration trait male 0 days 8 0.27 null 0.01 0.03 p-aminohippurate analysis by liquid phase colorimetry 0.0 PA IV 50mg/kg 490 days 100479 2479
SD renal filtration fraction streptozotocin (60 mg/kg) then insulin then Moexipril (30-35 mg/kg/d) (for 112 days) Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. glomerular filtration trait male 0 days 8 0.29 null 0.01 0.02 p-aminohippurate analysis by liquid phase colorimetry 0.0 stz 154 days GFR by inulin method 99912 2358
SD renal filtration fraction streptozotocin (60 mg/kg) then insulin Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. glomerular filtration trait male 0 days 8 0.29 null 0.0 0.01 p-aminohippurate analysis by liquid phase colorimetry 0.0 stz 224 days GFR by inulin method 99932 2358
MWF/Ztm renal filtration fraction arterial catheter implantation and controlled hemorrhage Remuzzi A, etal., Kidney Int. 1988 Oct;34(4):481-6. doi: 10.1038/ki.1988.206. glomerular filtration trait male 126 days-147 days 8 0.32 null 0.02 0.06 p-aminohippurate analysis by liquid phase colorimetry 0.0 0 109247 3138
WKY renal filtration fraction puromycin aminonucleoside (50 mg/kg) Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. glomerular filtration trait male 0 days 7 0.09 null 0.0 0.01 p-aminohippurate analysis by liquid phase colorimetry 0.0 PA IV 50mg/kg 15 days 100473 2479
WKY renal filtration fraction controlled enalapril content drinking water (50 mg/l) (for 7 days) then puromycin aminonucleoside (50 mg/kg) Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. glomerular filtration trait male 0 days 8 0.28 null 0.01 0.03 p-aminohippurate analysis by liquid phase colorimetry 0.0 PA IV 50mg/kg 0 100477 2479
WKY renal filtration fraction puromycin aminonucleoside (50 mg/kg) Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. glomerular filtration trait male 0 days 9 0.32 null 0.02 0.06 p-aminohippurate analysis by liquid phase colorimetry 0.0 PA IV 50mg/kg 0 100604 2479
MWF/ZtmRrrc renal filtration fraction control condition Remuzzi A, et al., J Clin Invest. 1990 Feb;85(2):541-9. glomerular filtration trait male 126 days 7 0.19 null 0.02 0.06 p-aminohippurate analysis by liquid phase colorimetry 0.0 0 100943 2541
MWF/ZtmRrrc renal filtration fraction control condition Remuzzi A, et al., J Clin Invest. 1990 Feb;85(2):541-9. glomerular filtration trait male 246 days 8 0.27 null 0.01 0.04 p-aminohippurate analysis by liquid phase colorimetry 0.0 0 100945 2541
SD renal filtration fraction streptozotocin (60 mg/kg) then insulin Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. glomerular filtration trait male 0 days 8 0.3 null 0.01 0.03 p-aminohippurate analysis by liquid phase colorimetry 0.0 stz 154 days GFR by inulin method 99911 2358
SD renal filtration fraction control condition Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. glomerular filtration trait male 0 days 8 0.3 null 0.01 0.02 p-aminohippurate analysis by liquid phase colorimetry 0.0 0 GFR by inulin method 99913 2358
SD renal filtration fraction streptozotocin (60 mg/kg) then insulin then Moexipril (30-35 mg/kg/d) (for 112 days) Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. glomerular filtration trait male 0 days 8 0.29 null 0.01 0.02 p-aminohippurate analysis by liquid phase colorimetry 0.0 stz 224 days GFR by inulin method 99933 2358
WKY renal filtration fraction puromycin aminonucleoside (50 mg/kg) Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. glomerular filtration trait male 0 days 9 0.34 null 0.02 0.06 p-aminohippurate analysis by liquid phase colorimetry 0.0 PA IV 50mg/kg 0 100476 2479
WKY renal filtration fraction 0.9% sodium chloride solution (3 ml) Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. glomerular filtration trait male 0 days 9 0.32 null 0.03 0.09 p-aminohippurate analysis by liquid phase colorimetry 0.0 0 100478 2479
WKY renal filtration fraction puromycin aminonucleoside (50 mg/kg) then saralasin (0.3 mg/kg/hr) (for 0.5 hours) Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. glomerular filtration trait male 0 days 9 0.32 null 0.01 0.03 p-aminohippurate analysis by liquid phase colorimetry 0.0 PA IV 50mg/kg 0 100605 2479
WKY renal filtration fraction puromycin aminonucleoside (50 mg/kg) then 0.9% sodium chloride solution (for 0.5 hours) Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. glomerular filtration trait male 0 days 9 0.28 null 0.03 0.09 p-aminohippurate analysis by liquid phase colorimetry 0.0 PA IV 50mg/kg 0 100607 2479
WKY renal filtration fraction 0.9% sodium chloride solution (3 ml) Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. glomerular filtration trait male 0 days 8 0.26 null 0.01 0.03 p-aminohippurate analysis by liquid phase colorimetry 0.0 0 100475 2479
SD renal filtration fraction control condition Perico N, et al., J Am Soc Nephrol. 1994 Oct;5(4):1139-46. glomerular filtration trait male 0 days 8 0.29 null 0.0 0.01 p-aminohippurate analysis by liquid phase colorimetry 0.0 0 GFR by inulin method 99934 2358
WKY renal filtration fraction controlled enalapril content drinking water (50 mg/l) (for 497 days) then puromycin aminonucleoside (50 mg/kg) Anderson S, et al., J Clin Invest. 1988 Nov;82(5):1757-68. glomerular filtration trait male 0 days 9 0.28 null 0.01 0.03 p-aminohippurate analysis by liquid phase colorimetry 0.0 PA IV 50mg/kg 490 days 100480 2479